FUNDAMENTALS |
MarketCap: |
15.68 mill
|
EPS: |
0
|
P/E: |
0
|
Earnings Date: |
May 14, 2024 |
SharesOutstanding: |
520.08 mill
|
Avg Daily Volume: |
0.0619 mill
|
RATING
2024-05-03 |
B
|
Neutral
|
RATINGS |
Rating CashFlow: |
Strong Sell
|
|
Return On Equity: |
Sell
|
|
Return On Asset: |
Sell
|
|
DE: |
Strong Buy
|
|
P/E: |
Strong Sell
|
|
Price To Book: |
Strong Buy
|
|
QUARTER GROWTHS |
|
3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 |
Revenue | | | | | | |
Gr.Profit | | | | | | |
Ebit | | | | | | |
Asset | | | | | | |
Debt | | | | | | |
PE RATIO: COMPANY / SECTOR |
0.00x
|
Company: PE 0 | sector: PE -11.58
|
PE RATIO: COMPANY / INDUSTRY |
N/A
|
Company: PE 0 | industry: PE -1.310
|
DISCOUNTED CASH FLOW VALUE |
$-0.0181
(-159.92%)
$-0.0482
|
Date: 2024-05-04
|
Expected Trading Range (DAY) |
$ 0.0262 - 0.0342
( +/- 13.27%)
|
ATR Model: 14 days
|
Insider Trading
Date |
Person |
Action |
Amount |
type |
2023-03-03 | Atcher Robert | Buy | 750 000 | Common Stock |
2023-12-14 | Cox W Matthew | Buy | 250 000 | Common Stock |
2023-12-14 | Bagerdjian Shahe | Buy | 1 000 000 | Common Stock |
2023-09-05 | Bagerdjian Shahe | Buy | 2 500 000 | Common Stock |
2023-09-05 | Bagerdjian Shahe | Sell | 778 972 | Common Stock |
INSIDER POWER |
83.84
|
Last
98 transactions |
Buy:
96 694 250 | Sell:
53 229 684 |
Forecast:
16:00 - $0.0302
Live Trading Signals (every 1 min)
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals |
RSI 21 |
|
SMA |
|
Trend |
|
Trend 2 |
|
Trend 3 |
|
Volume Signals |
Price |
$0.0302 (-22.09% )
|
Volume |
0.0376 mill
|
Avg. Vol. |
0.0619 mill
|
% of Avg. Vol |
60.76 %
|
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For INIS
0 Signals |
Accuracy: 0.00% | Accuracy
Buy: 0.00% | Accuracy
Sell: 0.00%
Avg return
buy: 0.00 % | Avg return
sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
International Isotopes Inc. manufactures and sells nuclear medicine calibration and reference standards, cobalt-60 products, and radiopharmaceutical and radiochemical contract manufacturing services in the United States and internationally. It operates through five segments: Nuclear Medicine Standards, Cobalt Products, Radiochemical Products, Radiological Services, and Fluorine Products. The Nuclear Medicine Standards segment manufactures sources and standards associated with single photon emission computed and positron emission tomography imaging, patient positioning, and calibration or operational testing of dose measuring equipment for the nuclear pharmacy industry. It offers flood sources, dose calibrators, rod sources, flexible and rigid rulers, spot and pen point markers, and various specialty design items. The Cobalt Products segment produces bulk cobalt; fabricates cobalt capsules for radiation therapy and various industrial applications; and recycles expended cobalt sources. The Radiochemical Products segment produces and distributes various isotopically pure radiochemicals and sodium iodide I-131 generic drug product for medical, industrial, and research applications. The Radiological Services segment provides flood source disposal and gemstones processing services. The Fluorine Products segment is involved in the production of small-scale qualification samples of high purity fluoride gas for various industrial applications, as well as development of laboratory and analytical processes required to support the planned uranium de-conversion and fluorine extraction facility. It sells its products directly to end users and distributors. International Isotopes Inc. was incorporated in 1995 and is headquartered in Idaho Falls, Idaho.